Eli Lilly has reported impressive results from a large Phase 3 clinical trial of its experimental obesity drug, retatrutide. The drug helped patients lose significantly more weight than expected and also reduced knee pain linked to osteoarthritis. However, some patients stopped treatment due to side effects, raising questions about how well people can tolerate the
Mounjaro Shows Promise for Kids and Teens with Type 2 Diabetes Eli Lilly’s diabetes drug Mounjaro (tirzepatide) is moving closer to approval for children and teens after strong results from a new clinical trial. The phase 3 SURPASS-PEDS study tested the drug in 99 patients ages 10 to 17 who struggled to control their blood
As 2024 draws to a close, groundbreaking advancements have defined the year, spanning medicine, space exploration, and ancient history. Here are the top discoveries: 1. HIV Prevention Breakthrough The drug lenacapavir, used as an HIV preventative, achieved stunning success in trials, with up to 100% efficacy. Administered biannually as an injection, it targets HIV’s capsid
Your thyroid plays a big role in your health, but many people don’t realize how much it affects their body until there’s a problem. The good news? You can take steps to keep your thyroid healthy and manage thyroid conditions effectively if they occur. How to Prevent Thyroid Problems While not all thyroid issues
Introducing peanut products to children early can significantly reduce the risk of developing peanut allergies, according to recent research. Children who consumed peanut pastes or peanut snacks regularly from four to six months old were found to be 71% less likely to have a peanut allergy by age 13 compared to those who avoided peanuts.
Researchers have found that wrist-worn health devices can be combined with machine learning to detect COVID-19 infections as early as two days before symptoms appear, and this could open the door to applying the use of wearable health tech for the early detection of other infectious diseases. The “COVI-GAPP” study was conducted by researchers from
Researchers have found that bilingualism can slow down and mitigate the course of age-related changes in the human brain. The study is authored by scientists from the Institute of Cognitive Neuroscience in Moscow, Vita-Salute San Raffaele University in Milan and Northumbria University in Newcastle. A sample of cognitively healthy senior (60+ years of age) bilingual
